Investor Presentation Setting the new standard for cannabis-based nutraceuticals and sports medicine therapies
ALIGNED WITH POWERFUL TRENDS US $22 Billion Expected size of Canadian cannabis market (recreational and medical) by 2022 US $70 Billion Projected size of the total cannabis market within the United States by 2022 US $52 Billion Anticipated global market size of the nutraceuticals sector by 2022 Orion is well-positioned to capitalize on powerful emerging trends in both the international cannabis and nutraceutical sectors and to become a world- Market share of cannabis extracts, oils, 80% of the class brand differentiated by the quality, variety, and other derivatives produced after extraction (versus 20% for dried bud) price point, and marketing of our products. total market Orion is executing a comprehensive plan to become a global leader in the production of Potential size of the of the eventual medical and recreational cannabinoid extracts international consumer market for US $500 Billion cannabis (medical & recreational) and oils, nutraceuticals, and pharmaceuticals. 0 1 | O R I O N N U T R A C E U T I C A L S | I N V E S T O R P R E S E N T A T I O N
ORION EXECUTIVE SUMMARY MISSION Orion Nutraceuticals will set a new standard within Cannabis Life Sciences by producing and developing innovative products with key strategic partners in the FUNDING REQUIREMENTS industry. These partnerships contribute to our competitive advantages, which include low production costs, industrial-scale, high-quality, and global distribution. ORION IS SEEKING EQUITY GROWTH CAPITAL: In order for the cannabis industry to reach its full potential it must reliably supply consumers with a variety of high-quality, tested, consistent, and safe products at an affordable price. All these are key strengths and capabilities of Orion. Office & Admin WHY ORION? 25% HIGH-POTENTIAL PLATFORM Diversified, high-margin revenue streams (products & oils) <5¢ cost/gram of dried flower (Colombia) Distribution channels in NA, EU, LATAM Pipeline of relationships & acquisition targets Advertising & Marketing 10% LESS OPERATIONAL RISK Building & Equipment 65% Industry-proven senior management team Rigorous, transparent governance model Execution, construction, operating expertise Large scale cultivation & extraction know-how PROJECTED USE OF PROCEEDS MEANINGFUL INNOVATION 40+ potentially patentable formulations ORION NUTRACEUTICALS IS PUBLICLY LISTED ON THE Portfolio of unique sports medicine products CANADIAN STOCK EXCHANGE (CSE: ORI) Advancements in new ingestion methods AND IS IN THE PROCESS OF ACQUIRING HEALTH CANADA Developing target, high-resin genetic strains PRODUCTION, DISTRIBUTION, IMPORT/EXPORT LICENSES 0 2 | O R I O N N U T R A C E U T I C A L S | I N V E S T O R P R E S E N T A T I O N
SEASONED MANAGEMENT TEAM The Orion senior management team possesses significant industry experience (including as a licensed producer), deep relationships, access to the most recent cultivation and production technologies, and specialized cannabis and capital markets knowledge on par with the largest publicly listed companies in the sector. Marcelin O ' Neill Robin Linden Jonathan Fiteni Christopher Cherry CEO , Director CFO , Director CCO , Director Independent Director Jonathan Fiteni is a cannabis pioneer Christopher Cherry has over 15 years of Marcie O'Neill brings over 24 years of Robin Linden contributes over 20 who has worked over 15 years to corporate accounting and audit experience in the management of years of leadership and management actively bridge the divide between experience, having been a Chartered public companies, including expertise experience, including roles at the global investment capital and legal Accountant (CA) since February 2009 in the areas of corporate governance University of Manitoba, Molson growers, suppliers, researchers, and and a Certified General Accountant and affairs, regulatory and compliance, Breweries Canada, Canadian luxury medical professionals who have (CGA) since 2004. and financial/operational oversight. retailer – Holt Renfrew, and Fairmont dedicated their lives to transforming Hotels and Resorts. the cannabis industry. Mr. Cherry has held a number of senior- Ms. O'Neill is the Managing Director of level positions, including as a Senior Accrete Consulting, Inc., which delivers Mr. Linden currently sits on the board Mr. Fiteni has guided several industry Accountant at KPMG and as an Auditor corporate governance and of directors for MYM Nutraceuticals, startups, raised millions in capital for at Davidson and Co. LLP in Vancouver. management services to public a publicly traded Canadian medical both private and public companies Mr. Cherry has also served at the companies. cannabis company. He has been and developed more than 40 patent director and officer levels for a number instrumental in initiating various pending cannabis formulations. of public mining companies. Mr. Cherry Ms. O'Neill has served as a Director for projects, including the current is the founder of Cherry Consulting, Ltd. a number of firms, including Alternate construction of over 2.7 million Most recently Mr. Fiteni was the CEO Health Corp., Jagercor Energy Corp., square feet of cannabis production and Director of Operations for MYM Mr. Cherry earned a Bachelors of Cervantes Capital Corp., and space in Canada and Australia. Mr. Nutraceuticals, Inc. a publicly listed Technology in Accounting from the Mandalay Resources Corporation. Linden brings with him experience in (CSE) company focused on building British Columbia Institute of Technology. the branding and sales of a variety of large, licensed production facilities Ms. O'Neill is a graduate of the British cannabis-based products. to serve the pharmaceutical-grade Columbia Institute of Technology with and recreational cannabis markets. a degree in Business Management. Ms. Mr. Linden holds a Bachelor of Arts O'Neill has also successfully completed degree (with honours) from the Mr. Fiteni graduated from the British the Canadian Securities Course and University of Manitoba and obtained Columbia Institute of Technology the Conduct and Practices Handbook, post graduate diplomas from both with a Business Administration and both with Honours. Simon Fraser University (Vancouver) Management degree. and the University of St. Andrews (Scotland). 0 3 | O R I O N N U T R A C E U T I C A L S | I N V E S T O R P R E S E N T A T I O N
ORION PRODUCTS & SOLUTIONS Orion will use cannabis extracts and oils as the foundation to develop an innovative line of branded nutraceutical and pharmaceutical products, as well as sell bulk oils to meet global industry demand. Retailers, Distributors, Homeopathic Pharmaceutical Wholesalers Sales Channels Sales Channels SPORTS MEDICINE Medicinal Products Over-the-Counter Products Transdermal Patches Personal Care Products Topical Gels Massage Oils Creams CBD Sports Drinks Orion First Mover Advantages Sprays Time-Released CBD Sports Wraps Capsules Sports Medicine Products Tinctures As the CBD market continues to evolve and expand through Aerosols increased awareness and advances in research, Sublingual Medication nutraceutical science is becoming heavily involved. Orion Buccal Medication is helping open the door to a new range of CBD-based and Pharmaceutical-Grade Products CBD-infused products which offer potentially better solutions for pain management, reduced inflammation, Bulk Extracts & Oils faster recovery times, and the offsetting of brain injuries. Full Spectrum Oils CBD Isolates Orion has an aggressive strategy, in partnership with Other Targeted Cannabinoids leading research organizations, professional athletes, and Terpenes sports leagues, to introduce and promote an innovative line Micro-Emulsions of sports medicine therapies and related wellness products. 0 4 | O R I O N N U T R A C E U T I C A L S | I N V E S T O R P R E S E N T A T I O N
ORION TRANSDERMAL PATCHES Transdermal cannabis patches are a unique method of cannabis consumption. A patch with a special adhesive is applied to a veinous area of the body, and the cannabinoids (cannabis chemical compounds) enter the bloodstream for an effective and long-lasting response. They can be used for pain and sleep management amongst other medical benefits. Transdermal applications are an alternative option for users who do not want or cannot, consume cannabis by inhaling or ingesting the medication. Orion will work to develop transdermal patches, with formulations including CBD, THC, THC-A, CBG, CBN, and / or other desired ADVANTAGES blends of cannabinoids. Orion's transdermal patches and topical gels are advisable solutions for the following conditions: Fibromyalgia More uniform plasma levels as delivery are controlled Peripheral Neuropathic Pain through the skin and into circulation Parkinson's Disease Reduced side effects due to the reduction of peaks in Schizophrenia plasma levels Autism Improved patient compliance due to the reduced Post-Traumatic Stress Disorder (PTSD) dosing frequency Epilepsy (99% CBD formulation) Avoids first - pass effects with increased bioavailability Multiple Sclerosis A non - invasive method of cannabis consumption Dravet Syndrome No " peaks " and valleys " as seen with oral administration ( inhaling or ingesting cannabis ) Simple removal of the patch can reverse any potential adverse side effects , allowing for a more controlled and comfortable experience 0 5 | O R I O N N U T R A C E U T I C A L S | I N V E S T O R P R E S E N T A T I O N
Recommend
More recommend
